The Trip Treatment

In this New Yorker article, the author explores the growing interest in using psychedelic drugs, particularly psilocybin and MDMA, in therapeutic settings. The article delves into the history of psychedelic research and the renewed scientific interest in these substances. It discusses the potential benefits of psychedelic-assisted therapy for treating various mental health conditions, including PTSD and anxiety. The author also highlights the experiences of individuals who have undergone these treatments and the positive outcomes they have reported. Overall, the article provides a thought-provoking look at the potential therapeutic applications of psychedelic drugs.